Skip to main content
HR 427 118th Congress House Health Abortion Drug safety, medical device, and laboratory regulation Health information and medical records Health personnel Health technology, devices, supplies Marketing and advertising Prescription drugs

SAVE Moms and Babies Act of 2023

Introduced: December 11, 2023 Introduced by: Latta, Robert E. Republican · Ohio See on congress.gov
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 27, 2023
Referred to the Subcommittee on Health.
Jan 20, 2023
Introduced in House
Jan 20, 2023
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023

This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.

The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.

The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

What's happening now January 27, 2023

Referred to the Subcommittee on Health.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 111
R
Murphy, Gregory F.
North Carolina · Dec 16, 2024
R
Miller, Max L.
Ohio · Dec 6, 2024
R
Burlison, Eric
Missouri · Nov 18, 2024
R
Fong, Vince
California · Nov 18, 2024
R
Foxx, Virginia
North Carolina · Nov 18, 2024
R
Greene, Marjorie Taylor
Georgia · Nov 18, 2024
R
Van Duyne, Beth
Texas · Nov 18, 2024
R
Maloy, Celeste
Utah · Jun 12, 2024
R
Burchett, Tim
Tennessee · Feb 5, 2024
Posey, Bill
· Jan 18, 2024
Buck, Ken
· Jan 3, 2024
R
Flood, Mike
Nebraska · Jan 3, 2024
R
Houchin, Erin
Indiana · Jan 3, 2024
R
Kelly, Trent
Mississippi · Jan 3, 2024
R
Self, Keith
Texas · Jan 3, 2024
R
Stauber, Pete
Minnesota · Jan 3, 2024
R
Westerman, Bruce
Arkansas · Jan 3, 2024
R
Bean, Aaron
Florida · Dec 19, 2023
R
Bilirakis, Gus M.
Florida · Dec 19, 2023
R
Brecheen, Josh
Oklahoma · Dec 19, 2023
R
Cammack, Kat
Florida · Dec 19, 2023
R
Estes, Ron
Kansas · Dec 19, 2023
R
Ezell, Mike
Mississippi · Dec 19, 2023
Graves, Garret
· Dec 19, 2023
R
Hern, Kevin
Oklahoma · Dec 19, 2023
R
McCormick, Richard
Georgia · Dec 19, 2023
R
Miller, Carol D.
West Virginia · Dec 19, 2023
R
Moolenaar, John R.
Michigan · Dec 19, 2023
Mooney, Alexander
· Dec 19, 2023
R
Moore, Barry
Alabama · Dec 19, 2023
R
Moore, Blake D.
Utah · Dec 19, 2023
Pence, Greg
· Dec 19, 2023
R
Rouzer, David
North Carolina · Dec 19, 2023
R
Sessions, Pete
Texas · Dec 19, 2023
R
Smith, Adrian
Nebraska · Dec 19, 2023
R
Thompson, Glenn
Pennsylvania · Dec 19, 2023
R
Wilson, Joe
South Carolina · Dec 19, 2023
R
Bentz, Cliff
Oregon · Dec 11, 2023
R
Bice, Stephanie I.
Oklahoma · Dec 11, 2023
R
Cline, Ben
Virginia · Dec 11, 2023
Duncan, Jeff
· Dec 11, 2023
R
Jordan, Jim
Ohio · Dec 11, 2023
R
Kustoff, David
Tennessee · Dec 11, 2023
R
Loudermilk, Barry
Georgia · Dec 11, 2023
R
Webster, Daniel
Florida · Dec 11, 2023
R
Hudson, Richard
North Carolina · Oct 20, 2023
R
Crenshaw, Dan
Texas · Sep 19, 2023
R
LaMalfa, Doug
California · Sep 14, 2023
R
Rogers, Mike D.
Alabama · Sep 14, 2023
R
Strong, Dale W.
Alabama · Sep 14, 2023
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 427: SAVE Moms and Babies Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-427/
MLA
"H.R. 427: SAVE Moms and Babies Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-427/.
Bluebook (legal)
H.R. 427, 118th Cong. (2026), https://openamerica.io/bill/118-HR-427/.
Markdown link
[H.R. 427: SAVE Moms and Babies Act of 2023](https://openamerica.io/bill/118-HR-427/)
Report a problem